When and How Would You Screen This Patient for Cervical Cancer? : Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
- Resource Type
- journal article
- Authors
- Reynolds, Eileen E.; Weinstein, Amy; Farid, Huma; Libman, Howard
- Source
- Annals of Internal Medicine. Feb2022, Vol. 175 Issue 2, p267-275. 9p. 2 Diagrams, 3 Charts.
- Subject
- *CERVICAL cancer
*MEDICAL screening
*CANCER patients
*MEDICAL centers
*EARLY detection of cancer
- Language
- ISSN
- 0003-4819
Successful screening programs based on cervical cytology have dramatically reduced the incidence of cervical cancer in the United States. Human papillomavirus immunization is poised to reduce it further as an increasing percentage of vaccinated women reach adulthood. A recent guideline from the American Cancer Society advises that cervical cancer screening begin at age 25 and that high-risk human papillomavirus testing is the preferred screening test. The U.S. Preventive Services Task Force recommends screening begin at age 21 and that cytology remain incorporated into screening. Here, 2 experts debate how to apply these guidelines to Ms. L, a 22-year-old woman who has never undergone cervical cancer screening. [ABSTRACT FROM AUTHOR]